GCPNX | JHTAX | GCPNX / JHTAX | |
Total Expense Ratio | 0.63 | 0.85 | 74% |
Annual Report Gross Expense Ratio | 1.05 | 0.85 | 124% |
Fund Existence | 8 years | 4 years | - |
Gain YTD | -0.342 | 0.034 | -1,016% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 260M | 3.25B | 8% |
Annual Yield % from dividends | 0.75 | 0.47 | 159% |
Returns for 1 year | 6.88 | 6.33 | 109% |
Returns for 3 years | 42.79 | 37.00 | 116% |
Returns for 5 years | 69.63 | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTAX | 26.51 | -0.17 | -0.64% |
Fidelity Advisor Biotechnology A | |||
MSBVX | 11.93 | -0.15 | -1.24% |
Morgan Stanley American Resilience I | |||
HSMNX | 35.74 | -0.49 | -1.35% |
Horizon Multi-Factor Small/Mid Cap Inv | |||
CCRZX | 14.71 | -0.23 | -1.54% |
Columbia Disciplined Core Inst | |||
HRITX | 12.64 | -0.25 | -1.94% |
Hood River International Opportunity Ret |